Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €196.00 | €237.94 | 21.398% |
| Idexx Laboratories Inc. | 12 | 0 | 2 | 0 | €504.20 | €550.70 | 9.223% |
| Esperion Therapeutis.Inc. | 14 | 0 | 2 | 0 | €2.12 | €8.39 | 295.949% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €28.00 | €47.53 | 69.743% |
| Adaptimmune Therapeutics PLC ADR | 3 | 0 | 3 | 0 | €1.14 | €1.70 | 49.123% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.42 | €26.01 | 33.950% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €373.30 | €421.61 | 12.940% |
| Sutro Biopharma Inc | 21 | 0 | 3 | 0 | €3.96 | €11.04 | 178.848% |
| Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €82.87 | €88.17 | 6.395% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €149.90 | €179.60 | 19.810% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €202.80 | €207.72 | 2.424% |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | €8.90 | €17.78 | 99.766% |
| ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | €1.76 | €3.03 | 72.409% |
| LivaNova plc | 9 | 0 | 3 | 0 | €56.00 | €66.59 | 18.916% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.60 | €20.43 | 76.142% |
| Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €22.60 | €68.78 | 204.333% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €42.13 | €50.33 | 19.470% |
| Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.37 | €63.93 | 16993.850% |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €44.47 | €41.65 | -6.347% |
| Atossa Genetics Inc | 7 | 1 | 3 | 0 | €1.48 | €3.74 | 151.995% |
| Select Medical Holdings | 6 | 0 | 3 | 0 | €32.20 | €36.41 | 13.064% |
| Humana Inc. | 23 | 0 | 3 | 0 | €319.00 | €439.88 | 37.892% |
| Icon plc | 18 | 0 | 3 | 0 | €295.70 | €319.67 | 8.106% |